Blood test, DNA

Creating the Future of Cell and Gene Therapies

In this GEN webinar, sponsored by PerkinElmer, our distinguished presenters will provide perspectives on how the gene therapy field ought to evolve. From the early vector systems, which often represented replicating viruses, to the recent sophisticated engineering of targeted virus driven cell and gene therapies that have demonstrated clinical benefits and gained FDA approval for multiple diseases.
Coronavirus COVID-19 and blood cells in bloodstream

Accelerating Vaccine Development Using a Next-Gen Microfluidic CE Platform

In this GEN webinar, sponsored by PerkinElmer, we will find out about an exciting protein characterization system that addresses many of the challenges researchers face during vaccine development projects. We will also learn about key applications of microfluidic chip-capillary electrophoresis in vaccine process development.

Accelerating Vaccine Development and Large-Scale Manufacturing with Advanced Purification Tools

Join this GEN webinar, sponsored by Thermo Fisher Scientific, and learn more on novel purification solutions that can help accelerate early vaccine candidate screening and improve the downstream process of different vaccine modalities such as mRNA, recombinant proteins, and Virus-Like Particles (VLPs). In addition, a new scavenging method for the removal of Baculovirus process impurities will be presented.
stocks go up

Trends and Takeaways from J.P. Morgan 2021

For our inaugural episode, GEN Edge Live will share notes, takeaways, and trends from the all-important J.P. Morgan 39th Annual Healthcare Conference—the first virtual JPM conference. Our guests will discuss the major news—blockbuster mergers and acquisitions, company partnerships, product and strategic announcements, and much more. GEN Edge Live will recount the key events of JPM 2021 and explore where biopharma and many of its key players are headed in the new year.
scientific research concept

GEN 40: Looking Back and Thinking Ahead

In the first episode of GEN Live for 2021, we’ll survey the state of biotech in 2021, relive some key moments in GEN’s first 40 years, and anticipate where the industry is heading.
medication and syringe

Accelerating Vaccine Development through Use of Blood-Free Components

This GEN webinar, sponsored by Invitria, will discuss the real contamination risks described in a recent study and how companies are rising to this challenge through a better selection of components and excipients.
Adeno-associated viruses

Scalable AAV Manufacturing: Addressing Challenges Across the Workflow

In this GEN webinar, sponsored by Thermo Fisher Scientific, our presenters will highlight upstream and downstream solutions across the AAV production workflows. Specifically, we will learn about scalable, high-titer AAV production in two cell host systems.

High-Throughput Proteomics During a Pandemic

In this GEN webinar, sponsored by Bruker, our esteemed presenter Dr. Roman Fischer from the University of Oxford, will showcase the application and limitations of high-throughput timsTOF Pro mass spectrometry on large scale clinical sample sets in order to stratify patients and contribute to a multi-omics blood atlas of COVID-19 patients, and the combination of laser capture microdissection with proteomics methods for the 3D characterization of large biological macrostructures such as organs or tumors.
cancer cells

Combinatorial Immunotherapy Approaches for Patients with Advanced Solid Tumors

In this exciting new webinar, sponsored by Ultivue, we will explore the intratumoral administration of autologous, non-manipulated myeloid dendritic cells in combination with immune checkpoint inhibitors in patients with advanced solid tumors and in combination with the oncolytic virus talimogene laherparepvec (Imlygic®) in patients with advanced melanoma in phase I clinical trials.
Adeno-associated virus, illustration

AAV Based Gene Therapy for Rare Genetic Disorders: Strategies and Challenges

In this GEN webinar, sponsored by WuXi AppTec, we will review the challenges of utilizing AAV, as well as discuss in detail the recent progress and outstanding questions in AAV-based gene therapy.

Recently Featured

Scroll Up